AML with specific cytogenetic and mutational profiles shows differential DNA methylation profiles, in particular, DNMT3A and IDH gene mutations have been shown to have antagonistic patterns of enhancer DNA methylation, suggesting that epigenetic consequences of these mutations could be largely contributing to their malignant phenotype. This evidence concerns the gene DNMT3A and acute myeloid leukemia.